Effect of Comorbidity on Lung Cancer Diagnosis Timing and Mortality: A Nationwide Population-Based Cohort Study in Taiwan

Figure 3

Kaplan–Meier survival curve of lung cancer patients with and without comorbidity over the 16-year follow-up period.

(a) Overall survival of lung cancer patients with and without comorbidity (p<0.001)

(b) Overall survival of lung cancer patients with and without pulmonary comorbidities (p<0.001)

(c) Proportion of lung cancer diagnosis timing in subjects with different comorbidities (p<0.001)

(d) Overall survival of lung cancer patients with different comorbidities (p<0.001)